Silo Pharma, Inc. Share Price & Technical Analysis
SILO · $0.38 (+2.70%)
Healthcare / Biotechnology
$0.38
+2.70%
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's l…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
0% return in May, -9% avg return in past 3 year May month.
67% return in 2026, -24% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 33% | 33% | 0% | 0% | – | – | – | – | – | – | – | 67% |
| 25 | 78% | -18% | -8% | -33% | -43% | 20% | 33% | -25% | 17% | -29% | 0% | -40% | -47% |
| 24 | 0% | 7% | 18% | -5% | 11% | -52% | 110% | -43% | 0% | 0% | -9% | -10% | 25% |
| 23 | -7% | -15% | -5% | 10% | 5% | -5% | 0% | -10% | -11% | -6% | 0% | -7% | -50% |
| 22 | 11% | 0% | 30% | -25% | -10% | -24% | 25% | -4% | -19% | -34% | -8% | 0% | -58% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.48M
P/E ratio
—
52W high
$1.01
52W low
$0.22
Volume
2,16,366
Beta
0.77
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Silo Pharma, Inc. share price today?
- Silo Pharma, Inc. (SILO) last traded around $0.38 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SILO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SILO. Download the app for real-time alerts.
- How can I analyze Silo Pharma, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.